Marshall Wace North America L.P. - SATSUMA PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 46 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$79,000
-39.7%
16,888
-9.4%
0.00%
-100.0%
Q2 2021$131,000
-73.9%
18,642
-44.2%
0.00%
-66.7%
Q3 2019$501,000–33,380–0.00%–
 Download
Other shareholders

There were no reported owners of SATSUMA PHARMACEUTICALS INC in Q3 2021.

NameSharesValueWeighting ↓
View complete list of SATSUMA PHARMACEUTICALS INC shareholders